SAM
DNLI icon

Sectoral Asset Management’s Denali Therapeutics DNLI Stock Holding History

Sectoral Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,081
Closed -$248K – 101
2024
Q1 		$248K Sell
12,081
-800
-6% -$15K 0.1% 86
2023
Q4 		$276K Sell
12,881
-242,060
-95% -$4.79M 0.12% 95
2023
Q3 		$5.26M Buy
254,941
+9,650
+4% +$245K 1.02% 38
2023
Q2 		$7.24M Buy
245,291
+441
+0.2% +$12.4K 1.21% 32
2023
Q1 		$5.64M Buy
244,850
+1,000
+0.4% +$27.5K 1.08% 36
2022
Q4 		$6.78M Buy
243,850
+500
+0.2% +$14.9K 1.31% 23
2022
Q3 		$7.47M Buy
243,350
+41,250
+20% +$1.34M 1.47% 22
2022
Q2 		$5.95M Sell
202,100
-5,000
-2% -$131K 1.2% 32
2022
Q1 		$6.66M Buy
207,100
+17,500
+9% +$602K 1.18% 33
2021
Q4 		$8.46M Buy
189,600
+62,100
+49% +$2.94M 1.27% 32
2021
Q3 		$6.43M Buy
127,500
+62,500
+96% +$3.52M 0.53% 77
2021
Q2 		$5.1M Buy
65,000
+61,000
+1,525% +$3.77M 0.41% 86
2021
Q1 		$228K Buy
+4,000
New +$268K 0.02% 112
2020
Q3 		– Sell
-9,600
Closed -$232K – 114
2020
Q2 		$232K Buy
+9,600
New +$226K 0.02% 175

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sectoral Asset Management's DNLI Position: Q2 2024 in Review

Sectoral Asset Management sold out of Denali Therapeutics (DNLI) in Q2 2024, closing a stake of 12,081 shares — an estimated $248K sold.

Sectoral Asset Management first reported a position in DNLI in Q2 2020 and held it in 14 quarters. The position peaked at $8.46M in Q4 2021. 203 funds tracked by Wall St. Rank hold DNLI as of Q2 2024.

  • Sectoral Asset Management reported no remaining Denali Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 12,081 Denali Therapeutics shares in Q2 2024, an estimated $248K.
  • Sectoral Asset Management first reported a position in Denali Therapeutics in Q2 2020 and held it in 14 quarters.
  • Sectoral Asset Management's Denali Therapeutics position peaked at $8.46M in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2024.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.